 | • レポートコード：GIR-107A11982 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ワクチン技術のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ワクチン技術の種類別市場規模（感染症、アレルギー、がん）、用途別市場規模（人間、動物）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ワクチン技術の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Pfizer、Bayer、GE Healthcare、Glaxosmithkline、Johnson and Johnson、Thermo Fisher Scientific ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：感染症、アレルギー、がん ・用途別分析2016年-2026年：人間、動物 ・ワクチン技術の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ワクチン技術のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ワクチン技術のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ワクチン技術の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ワクチン技術の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vaccine Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vaccine Technologies size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Vaccine Technologies market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Vaccine Technologies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Infection
Allergy
Cancer
Market segment by Application, can be divided into
Humans
Animals
Market segment by players, this report covers
Abbott
Pfizer
Bayer
GE Healthcare
Glaxosmithkline
Johnson and Johnson
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Vaccine Technologies
1.2 Classification of Vaccine Technologies by Type
1.2.1 Overview: Global Vaccine Technologies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Vaccine Technologies Revenue Market Share by Type in 2020
1.2.3 Infection
1.2.4 Allergy
1.2.5 Cancer
1.3 Global Vaccine Technologies Market by Application
1.3.1 Overview: Global Vaccine Technologies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Humans
1.3.3 Animals
1.4 Global Vaccine Technologies Market Size & Forecast
1.5 Global Vaccine Technologies Market Size and Forecast by Region
1.5.1 Global Vaccine Technologies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Vaccine Technologies Market Size by Region, (2016-2021)
1.5.3 North America Vaccine Technologies Market Size and Prospect (2016-2026)
1.5.4 Europe Vaccine Technologies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Vaccine Technologies Market Size and Prospect (2016-2026)
1.5.6 South America Vaccine Technologies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Vaccine Technologies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine Technologies Market Drivers
1.6.2 Vaccine Technologies Market Restraints
1.6.3 Vaccine Technologies Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Vaccine Technologies Product and Solutions
2.1.4 Abbott Vaccine Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Vaccine Technologies Product and Solutions
2.2.4 Pfizer Vaccine Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Vaccine Technologies Product and Solutions
2.3.4 Bayer Vaccine Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bayer Recent Developments and Future Plans
2.4 GE Healthcare
2.4.1 GE Healthcare Details
2.4.2 GE Healthcare Major Business
2.4.3 GE Healthcare Vaccine Technologies Product and Solutions
2.4.4 GE Healthcare Vaccine Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GE Healthcare Recent Developments and Future Plans
2.5 Glaxosmithkline
2.5.1 Glaxosmithkline Details
2.5.2 Glaxosmithkline Major Business
2.5.3 Glaxosmithkline Vaccine Technologies Product and Solutions
2.5.4 Glaxosmithkline Vaccine Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Glaxosmithkline Recent Developments and Future Plans
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Vaccine Technologies Product and Solutions
2.6.4 Johnson and Johnson Vaccine Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Johnson and Johnson Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Vaccine Technologies Product and Solutions
2.7.4 Thermo Fisher Scientific Vaccine Technologies Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Vaccine Technologies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Vaccine Technologies Players Market Share
3.2.2 Top 10 Vaccine Technologies Players Market Share
3.2.3 Market Competition Trend
3.3 Vaccine Technologies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Vaccine Technologies Revenue and Market Share by Type (2016-2021)
4.2 Global Vaccine Technologies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Vaccine Technologies Revenue Market Share by Application (2016-2021)
5.2 Vaccine Technologies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Vaccine Technologies Revenue by Type (2016-2026)
6.2 North America Vaccine Technologies Revenue by Application (2016-2026)
6.3 North America Vaccine Technologies Market Size by Country
6.3.1 North America Vaccine Technologies Revenue by Country (2016-2026)
6.3.2 United States Vaccine Technologies Market Size and Forecast (2016-2026)
6.3.3 Canada Vaccine Technologies Market Size and Forecast (2016-2026)
6.3.4 Mexico Vaccine Technologies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Vaccine Technologies Revenue by Type (2016-2026)
7.2 Europe Vaccine Technologies Revenue by Application (2016-2026)
7.3 Europe Vaccine Technologies Market Size by Country
7.3.1 Europe Vaccine Technologies Revenue by Country (2016-2026)
7.3.2 Germany Vaccine Technologies Market Size and Forecast (2016-2026)
7.3.3 France Vaccine Technologies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Vaccine Technologies Market Size and Forecast (2016-2026)
7.3.5 Russia Vaccine Technologies Market Size and Forecast (2016-2026)
7.3.6 Italy Vaccine Technologies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Vaccine Technologies Revenue by Type (2016-2026)
8.2 Asia-Pacific Vaccine Technologies Revenue by Application (2016-2026)
8.3 Asia-Pacific Vaccine Technologies Market Size by Region
8.3.1 Asia-Pacific Vaccine Technologies Revenue by Region (2016-2026)
8.3.2 China Vaccine Technologies Market Size and Forecast (2016-2026)
8.3.3 Japan Vaccine Technologies Market Size and Forecast (2016-2026)
8.3.4 South Korea Vaccine Technologies Market Size and Forecast (2016-2026)
8.3.5 India Vaccine Technologies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Vaccine Technologies Market Size and Forecast (2016-2026)
8.3.7 Australia Vaccine Technologies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Vaccine Technologies Revenue by Type (2016-2026)
9.2 South America Vaccine Technologies Revenue by Application (2016-2026)
9.3 South America Vaccine Technologies Market Size by Country
9.3.1 South America Vaccine Technologies Revenue by Country (2016-2026)
9.3.2 Brazil Vaccine Technologies Market Size and Forecast (2016-2026)
9.3.3 Argentina Vaccine Technologies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Vaccine Technologies Revenue by Type (2016-2026)
10.2 Middle East & Africa Vaccine Technologies Revenue by Application (2016-2026)
10.3 Middle East & Africa Vaccine Technologies Market Size by Country
10.3.1 Middle East & Africa Vaccine Technologies Revenue by Country (2016-2026)
10.3.2 Turkey Vaccine Technologies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Vaccine Technologies Market Size and Forecast (2016-2026)
10.3.4 UAE Vaccine Technologies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Vaccine Technologies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Vaccine Technologies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Vaccine Technologies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Vaccine Technologies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Vaccine Technologies Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Vaccine Technologies Product and Solutions
Table 9. Abbott Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Vaccine Technologies Product and Solutions
Table 13. Pfizer Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bayer Corporate Information, Head Office, and Major Competitors
Table 15. Bayer Major Business
Table 16. Bayer Vaccine Technologies Product and Solutions
Table 17. Bayer Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 19. GE Healthcare Major Business
Table 20. GE Healthcare Vaccine Technologies Product and Solutions
Table 21. GE Healthcare Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Glaxosmithkline Corporate Information, Head Office, and Major Competitors
Table 23. Glaxosmithkline Major Business
Table 24. Glaxosmithkline Vaccine Technologies Product and Solutions
Table 25. Glaxosmithkline Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 27. Johnson and Johnson Major Business
Table 28. Johnson and Johnson Vaccine Technologies Product and Solutions
Table 29. Johnson and Johnson Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 31. Thermo Fisher Scientific Major Business
Table 32. Thermo Fisher Scientific Vaccine Technologies Product and Solutions
Table 33. Thermo Fisher Scientific Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Vaccine Technologies Revenue (USD Million) by Players (2019-2021)
Table 35. Global Vaccine Technologies Revenue Share by Players (2019-2021)
Table 36. Breakdown of Vaccine Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Vaccine Technologies Players Head Office, Products and Services Provided
Table 38. Vaccine Technologies Mergers & Acquisitions in the Past Five Years
Table 39. Vaccine Technologies New Entrants and Expansion Plans
Table 40. Global Vaccine Technologies Revenue (USD Million) by Type (2016-2021)
Table 41. Global Vaccine Technologies Revenue Share by Type (2016-2021)
Table 42. Global Vaccine Technologies Revenue Forecast by Type (2021-2026)
Table 43. Global Vaccine Technologies Revenue by Application (2016-2021)
Table 44. Global Vaccine Technologies Revenue Forecast by Application (2021-2026)
Table 45. North America Vaccine Technologies Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Vaccine Technologies Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Vaccine Technologies Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Vaccine Technologies Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Vaccine Technologies Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Vaccine Technologies Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Vaccine Technologies Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Vaccine Technologies Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Vaccine Technologies Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Vaccine Technologies Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Vaccine Technologies Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Vaccine Technologies Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Vaccine Technologies Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Vaccine Technologies Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Vaccine Technologies Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Vaccine Technologies Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Vaccine Technologies Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Vaccine Technologies Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Vaccine Technologies Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Vaccine Technologies Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Vaccine Technologies Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Vaccine Technologies Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Vaccine Technologies Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Vaccine Technologies Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Vaccine Technologies Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Vaccine Technologies Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Vaccine Technologies Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Vaccine Technologies Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Vaccine Technologies Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Vaccine Technologies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Vaccine Technologies Picture
Figure 2. Global Vaccine Technologies Revenue Market Share by Type in 2020
Figure 3. Infection
Figure 4. Allergy
Figure 5. Cancer
Figure 6. Vaccine Technologies Revenue Market Share by Application in 2020
Figure 7. Humans Picture
Figure 8. Animals Picture
Figure 9. Global Vaccine Technologies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Vaccine Technologies Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Vaccine Technologies Revenue Market Share by Region (2016-2026)
Figure 12. Global Vaccine Technologies Revenue Market Share by Region in 2020
Figure 13. North America Vaccine Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Vaccine Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Vaccine Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Vaccine Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Vaccine Technologies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Vaccine Technologies Market Drivers
Figure 19. Vaccine Technologies Market Restraints
Figure 20. Vaccine Technologies Market Trends
Figure 21. Abbott Recent Developments and Future Plans
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. Bayer Recent Developments and Future Plans
Figure 24. GE Healthcare Recent Developments and Future Plans
Figure 25. Glaxosmithkline Recent Developments and Future Plans
Figure 26. Johnson and Johnson Recent Developments and Future Plans
Figure 27. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 28. Global Vaccine Technologies Revenue Share by Players in 2020
Figure 29. Vaccine Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Vaccine Technologies Revenue Market Share in 2020
Figure 31. Global Top 10 Players Vaccine Technologies Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Vaccine Technologies Revenue Share by Type in 2020
Figure 34. Global Vaccine Technologies Market Share Forecast by Type (2021-2026)
Figure 35. Global Vaccine Technologies Revenue Share by Application in 2020
Figure 36. Global Vaccine Technologies Market Share Forecast by Application (2021-2026)
Figure 37. North America Vaccine Technologies Sales Market Share by Type (2016-2026)
Figure 38. North America Vaccine Technologies Sales Market Share by Application (2016-2026)
Figure 39. North America Vaccine Technologies Revenue Market Share by Country (2016-2026)
Figure 40. United States Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Vaccine Technologies Sales Market Share by Type (2016-2026)
Figure 44. Europe Vaccine Technologies Sales Market Share by Application (2016-2026)
Figure 45. Europe Vaccine Technologies Revenue Market Share by Country (2016-2026)
Figure 46. Germany Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Vaccine Technologies Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Vaccine Technologies Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Vaccine Technologies Revenue Market Share by Region (2016-2026)
Figure 54. China Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Vaccine Technologies Sales Market Share by Type (2016-2026)
Figure 61. South America Vaccine Technologies Sales Market Share by Application (2016-2026)
Figure 62. South America Vaccine Technologies Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Vaccine Technologies Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Vaccine Technologies Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Vaccine Technologies Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Vaccine Technologies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
世界の肺炎球菌ワクチン市場 2021：企業別、地域別、種類・用途別 The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界のヘモフィルスb結合型ワクチン（Hib）市場 2021：企業別、地域別、種類・用途別 The Haemophilus b Conjugate Vaccine (Hib) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 人間用狂犬病ワクチン市場：世界及び中国市場分析・予測（～2024年） Rabies Vaccine for Humans Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Rabies Vaccine for Humans industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rabies Vaccine for…
- 世界のワクチンアジュバント市場 2021：企業別、地域別、種類・用途別 The Vaccine Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界の水産養殖用自家ワクチン市場 2021：企業別、地域別、種類・用途別 The Autogenous Vaccine For Aquaculture market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…